Published in Bull World Health Organ on January 01, 1974
A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull World Health Organ (1980) 2.86
Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family. MBio (2014) 1.75
Mitogenicity of influenza hemagglutinin glycoproteins and influenza viruses bearing H2-hemagglutinin. Infect Immun (1981) 0.92
Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics. J Clin Microbiol (2014) 0.87
Cross talk between animal and human influenza viruses. Annu Rev Anim Biosci (2013) 0.83
The influenza virus: Antigenic composition and immune response. Postgrad Med J (1979) 0.75
Epidemiological and Phylogenetic Characteristics of Influenza B Infection in Severe Acute Respiratory Infection Cases in Beijing, 2014 to 2015. Medicine (Baltimore) (2015) 0.75
The application of the soluble antigen fluorescent antibody test for the diagnosis of avian influenza. Can J Comp Med (1981) 0.75
Influenza viruses in birds: rapid identification by counterimmunoelectrophoresis. J Clin Microbiol (1979) 0.75
Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation. Appl Microbiol (1969) 4.99
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion. J Gen Virol (1969) 3.11
Immunodiffusion studies on the reaction of influenza virus with specific antibody and nonspecific serum beta-inhibitor. Acta Virol (1966) 1.45
Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med (1977) 25.00
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
The epidemiology of AIDS: current status and future prospects. Science (1985) 8.73
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
Molecular mechanisms of variation in influenza viruses. Nature (1982) 5.54
The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25
Association of antigenic type of Herpesvirus hominis with site of viral recovery. J Immunol (1967) 5.07
A serologic study of herpesvirus hominis strains by microneutralization tests. J Immunol (1967) 4.39
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98
Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ (1975) 3.88
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
A quantitative, single-radial-diffusion test for immunological studies with influenza virus. J Gen Virol (1972) 3.69
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol (1968) 3.31
Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion. J Gen Virol (1969) 3.11
Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br Med J (1972) 3.10
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
The epidemiology of AIDS. Public Health Rep (1983) 3.00
Swine influenza viruses isolated in 1976 from man and pig contain two coexisting subpopulations with antigenically distinguishable hemagglutinins. Virology (1977) 2.90
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89
Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology (1985) 2.71
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study. Lancet (1969) 2.66
Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. Virology (1978) 2.61
Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology (1987) 2.58
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand (1977) 2.46
Genital infection with type 2 Herpes virus hominis. A commonly occurring venereal disease. Br J Vener Dis (1969) 2.40
Monoclonal antibodies which block cellular receptors of poliovirus. Virus Res (1984) 2.40
Relation of pock size on chorioallantoic membrane to antigenic type of herpesvirus hominis. Proc Soc Exp Biol Med (1968) 2.34
Effect of rubella vaccination programme on serological status of young adults in United Kingdom. Lancet (1979) 2.31
Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. Bull World Health Organ (1969) 2.28
Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med (1974) 2.25
Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med (1972) 2.24
Segregation of antigenic and biological characteristics during influenza virus recombination. J Gen Virol (1972) 2.18
Evidence for a new type-specific structural antigen of the influenza virus particle. J Gen Virol (1972) 2.17
Antibody against influenza A2 virus neuraminidase in human sera. J Hyg (Lond) (1969) 2.12
Isolation of swine influenza virus from autopsy lung tissue of man. N Engl J Med (1976) 2.09
Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science (1989) 2.03
Antigenic composition of recombinant virus strains produced from human and avian influenza A viruses. J Gen Virol (1969) 2.01
Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00
An antigenic variant of the Hong Kong-68 influenza A 2 virus. J Hyg (Lond) (1971) 1.95
Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J Infect Dis (1971) 1.90
Identification and preliminary antigenic analysis of swine influenza-like viruses isolated during an influenza outbreak at Fort Dix, New Jersey. J Infect Dis (1977) 1.88
Serological epidemiological studies with influenza A viruses. J Hyg (Lond) (1965) 1.86
Immunological relationships between the neuraminidases of human and animal influenza viruses. Bull World Health Organ (1969) 1.82
Natural history of influenza type A in the United States, 1957-1972. Prog Med Virol (1974) 1.79
Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3. Lancet (1982) 1.76
Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet (1975) 1.74
Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride. Br J Exp Pathol (1965) 1.73
Airways function during mild viral respiratory illnesses. The effect of rhinovirus infection in cigarette smokers. Ann Intern Med (1974) 1.72
Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J Gen Virol (1985) 1.72
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res (1984) 1.71
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
Immunological and physicochemical studies of influenza matrix (M) polypeptides. Virology (1976) 1.66
Protein composition of coronavirus OC 43. Virology (1972) 1.66
The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg (Lond) (1979) 1.65
Antigenic variation in current human type A influenza viruses: antigenic characteristics of the variants and their geographic distribution. Bull World Health Organ (1973) 1.60
Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man. Am J Epidemiol (1970) 1.60
An investigation of some factors affecting cross-reactivation between influenza A viruses. J Gen Virol (1971) 1.59
WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968. Bull World Health Organ (1970) 1.58
Age-related heterologous antibody responses to influenza virus vaccination. J Infect Dis (1977) 1.57
Neuraminidase in avin influenza A virus antigenically related to that of human A0 and A1 subtypes. Nature (1969) 1.56
Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgrad Med J (1973) 1.56
Studies with antibody to the purified haemagglutinin of an influenza Ao virus. J Gen Virol (1970) 1.56
Coronaviridae. Intervirology (1975) 1.55
Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy. Bull World Health Organ (1969) 1.55
Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. J Infect Dis (1997) 1.51
Swine influenza virus infections in humans. J Infect Dis (1977) 1.50
Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A 2 -Hong Kong infection. A controlled double-blind study. Lancet (1971) 1.49
Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. J Biol Stand (1980) 1.48
Antigenic analysis of influenza A virus surface antigens: considerations for the nomenclature of influenza virus. Brief review. Arch Virol (1980) 1.46
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45
Seroepidemiologic survey of coronavirus (strain OC 43) related infections in a children's population. Am J Epidemiol (1971) 1.44
Evidence for antigenic variation in influenza A nucleoprotein. Virology (1979) 1.43
Poliovirus type 3: molecular cloning of the genome and nucleotide sequence of the region encoding the protease and polymerase proteins. Nucleic Acids Res (1983) 1.43
Properties of the Hong Kong influenza virus. Antigenic relationship of the Hong Kong virus haemagglutinin to that of other human influenza A viruses. Bull World Health Organ (1969) 1.41
Epidemiology of influenza in the elderly: evidence of virus recycling. Am J Epidemiol (1976) 1.40
Studies on relationships between human and porcine influenza. 1. Serological evidence of infection in swine in Great Britain with an influenza A virus antigenically like human Hong Kong-68 virus. Bull World Health Organ (1972) 1.40
A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines. Bull World Health Organ (1975) 1.40
Epidemiological studies of rubella virus in a tropical African community. Bull World Health Organ (1980) 1.39
Live influenza vaccines. Lancet (1983) 1.39
Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. J Infect Dis (1977) 1.39